Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

569 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
Raghunandan S, Pauly M, Blum WG, Qayed M, Dhodapkar MV, Elkhalifa M, Watkins B, Schoettler M, Horwitz E, Parikh S, Chandrakasan S, Leung K, Bryson E, Deeb L, Kaufman JL, Worthington-White D, Alazraki A, Schecter JM, Madduri D, Jackson CC, Zudaire E, Taraseviciute-Morris A, Babich A, Nesheiwat T, Vogel M, Lendvai N, Pacaud L, Williams KM. Raghunandan S, et al. Among authors: horwitz e. J Immunother Cancer. 2023 May;11(5):e006684. doi: 10.1136/jitc-2023-006684. J Immunother Cancer. 2023. PMID: 37137553 Free PMC article.
Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature.
Hughes C, Harris A, Watkins B, Qayed M, Parikh S, Horwitz E, Stenger E, Williams KM, Schoettler ML. Hughes C, et al. Among authors: horwitz e. Pediatr Blood Cancer. 2023 Oct;70(10):e30606. doi: 10.1002/pbc.30606. Epub 2023 Aug 2. Pediatr Blood Cancer. 2023. PMID: 37533091 Review. No abstract available.
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
Patel PA, Teherani MF, Xiang Y, Bernardo V, Chandrakasan S, Goggin KP, Haight A, Horwitz E, Liang WH, Parikh SH, Schoettler ML, Spencer K, Stenger E, Watkins B, Williams KM, Leung K, Jaggi P, Qayed M. Patel PA, et al. Among authors: horwitz e. Transplant Cell Ther. 2023 Dec;29(12):778.e1-778.e6. doi: 10.1016/j.jtct.2023.09.011. Epub 2023 Sep 21. Transplant Cell Ther. 2023. PMID: 37739225 Free article.
Single-cell multiomics to advance cell therapy.
Goss K, Horwitz EM. Goss K, et al. Among authors: horwitz em. Cytotherapy. 2024 Oct 31:S1465-3249(24)00904-6. doi: 10.1016/j.jcyt.2024.10.009. Online ahead of print. Cytotherapy. 2024. PMID: 39530970 Review.
Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells.
Parwani KK, Branella GM, Burnham RE, Burnham AJ, Bustamante AYS, Foppiani EM, Knight KA, Petrich BG, Horwitz EM, Doering CB, Spencer HT. Parwani KK, et al. Among authors: horwitz em. Front Immunol. 2024 Feb 29;15:1331322. doi: 10.3389/fimmu.2024.1331322. eCollection 2024. Front Immunol. 2024. PMID: 38487542 Free PMC article.
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).
Geynisman DM, Abbosh PH, Ross E, Zibelman MR, Ghatalia P, Anari F, Mark JR, Stamatakis L, Hoffman-Censits JH, Viterbo R, Greenberg RE, Churilla TM, Horwitz EM, Hallman MA, Smaldone MC, Uzzo R, Chen DYT, Kutikov A, Plimack ER. Geynisman DM, et al. Among authors: horwitz em. J Clin Oncol. 2024 Dec 16:JCO2401214. doi: 10.1200/JCO-24-01214. Online ahead of print. J Clin Oncol. 2024. PMID: 39680823
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Azuly H, Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Azuly H, et al. Among authors: horwitz e. Infect Dis Ther. 2024 Dec 9. doi: 10.1007/s40121-024-01089-9. Online ahead of print. Infect Dis Ther. 2024. PMID: 39652286
569 results